Colorectal Cancer Trial, Recruiting NCT06819280 Sponsor: Grit Biotechnology Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT06819280
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are willing to take part voluntarily and are able to follow the study requirements, having signed a consent form
  • People aged between 18 and 70 years old
  • People who have advanced colorectal cancer that has continued to grow or spread after receiving first-line chemotherapy
  • People whose general health and ability to carry out daily activities is rated as 0 or 1 on a standard scale used by doctors (meaning fully active or able to carry out light work)
  • People whose doctors expect them to live for at least 12 weeks
  • People whose major organs (such as heart, liver, and kidneys) are functioning well
  • People who have imaging records (such as scans) showing their disease had progressed before a tumour tissue sample was taken
  • People who have at least one measurable area of cancer that can be tracked using standard medical imaging guidelines

Who may not be able to join:

  • People whose cancer-related pain is not well controlled, or who are taking pain medication that has not yet reached a stable, consistent dose; people with painful tumours that could be treated with targeted radiation therapy must have completed that treatment before joining
  • People with a known mental illness, or a history of alcoholism, drug use, or substance misuse
  • Women who are pregnant or breastfeeding, or who are planning to become pregnant within one year after receiving the cell treatment used in this trial
  • People who have taken part in another clinical trial involving an experimental drug within 4 weeks before a specific preparation treatment begins, or who plan to join another drug trial during this study
  • People whom the study doctors determine are not suitable for the trial for other medical reasons (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13501625681

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Grit Biotechnology
Registry
ClinicalTrials.gov
Start date
28 June 2024
Est. completion
27 May 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Incidence and severity of adcersed events per CTCAE 5.0; Objective response rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov